TXG - 10x Genomics, Inc.

22.97
-1.620   -7.053%

Share volume: 4,001,769
Last Updated: 04-21-2026
Measuring And Control Equipment/Lab Analytical Instruments: 0.27%

PREVIOUS CLOSE
CHG
CHG%
$24.59
-1.62
-0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
40%
Profitability 35%
Dept financing 23%
Liquidity 75%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.58%
1 Month
28.47%
3 Months
8.42%
6 Months
88.72%
1 Year
220.18%
2 Year
111.07%
Key data
Stock price
$22.97
P/E Ratio 
0.00
DAY RANGE
$22.88 - $25.18
EPS 
-$1.03
52 WEEK RANGE
$7.72 - $26.44
52 WEEK CHANGE
$208.92
MARKET CAP 
2.064 B
YIELD 
N/A
SHARES OUTSTANDING 
127.752 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-07-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$2,560,589
AVERAGE 30 VOLUME 
$2,289,507
Company detail
CEO: Serge Saxonov
Region: US
Website: 10xgenomics.com
Employees: 1,240
IPO year: 2019
Issue type:
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression.

Recent news